90
80
Growth Score 90 in past quarter
6 pts
Heat Score 80 in past quarter
14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
137407
Javelin Biotech is a predictive drug discovery platform intended to make an enhanced prediction of the performance of drugs in humans.
- Murat Cirit: CEO and Co-FounderPast Role: Massachusetts Institute of Technology, Director of Translational Center of Tissue Chip Technologies
- Kevin O'Handley: Co-Founder and VP of Business DevelopmentPast Role: Massachusetts Institute of Technology, Mentor at MIT Innovation Corps (I-Corps)
About the Company
Javelin Biotech is a framework for predictive drug discovery designed to improve drug performance prediction in humans. The company's platform enables biopharmaceutical companies to optimize ADME(T) and PD properties, which improve drug discovery and approval of the same, by bringing human-relevant in-vitro data and computational biology or
data analytics to pre-clinical drug discovery teams. This accelerates preclinical drug discovery and development by finding human-relevant targets.
Women Founded